Deutsche Bank Ag\ Avalo Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.0 - $10.45 $338,775 - $1.18 Million	-112,925 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$7.57 - $21.72 $558,083 - $1.6 Million	73,723 Added 188.06%	112,925 $82,000
Q4 2021 Feb 11, 2022	BUY	$19.68 - $28.68 $145,789 - $212,461	7,408 Added 23.3%	39,202 $66,000
Q3 2021 Nov 04, 2021	BUY	$26.16 - $40.68 $831,731 - $1.29 Million	31,794 New	31,794 $69,000

34.6K

Ticker AVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,414,100
Market Cap $88.5M
Description
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.